Cheryl A. Madsen
Algemeen Adviseur bij VIRACTA THERAPEUTICS, INC.
Actieve functies van Cheryl A. Madsen
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| VIRACTA THERAPEUTICS, INC. | Algemeen Adviseur | - | - |
Loopbaan van Cheryl A. Madsen
Eerdere bekende functies van Cheryl A. Madsen
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| PELOTON THERAPEUTICS, INC. | Algemeen Adviseur | - | - |
| Medivation, Inc. /Old/ | Corporate Officer/Principal | - | - |
| CALITHERA BIOSCIENCES, INC. | Algemeen Adviseur | - | - |
Opleiding van Cheryl A. Madsen
| University of California, Santa Cruz | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| General Counsel | 3 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| VIRACTA THERAPEUTICS, INC. | Health Technology |
| CALITHERA BIOSCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Peloton Therapeutics, Inc.
 Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Peloton Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in translating novel scientific insights into medicines for patients with cancer and other debilitating or life-threatening conditions. Its lead drug candidate is a small molecule which targets HIF-2a, a transcription factor implicated in the development and progression of renal and other cancers. The company was founded by Steven L. McKnight in August 2010 and is headquartered in Dallas, TX. | Health Technology |
| Medivation, Inc. /Old/ | Health Technology |
- Beurs
- Insiders
- Cheryl A. Madsen
- Ervaring
